0000950170-24-077930.txt : 20240626 0000950170-24-077930.hdr.sgml : 20240626 20240626165445 ACCESSION NUMBER: 0000950170-24-077930 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240624 FILED AS OF DATE: 20240626 DATE AS OF CHANGE: 20240626 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Shair Matthew CENTRAL INDEX KEY: 0001862123 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40671 FILM NUMBER: 241074316 MAIL ADDRESS: STREET 1: ONE BROADWAY, 14TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02142 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Nuvalent, Inc. CENTRAL INDEX KEY: 0001861560 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE BROADWAY, 14TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 508-446-2272 MAIL ADDRESS: STREET 1: ONE BROADWAY, 14TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02142 4 1 ownership.xml 4 X0508 4 2024-06-24 0001861560 Nuvalent, Inc. NUVL 0001862123 Shair Matthew C/O NUVALENT, INC. ONE BROADWAY, 14TH FLOOR CAMBRIDGE MA 02142 true false false false true Class A Common Stock 2024-06-24 4 S false 634 79.47 D 233888 I See Footnote Class A Common Stock 2024-06-24 4 S false 1176 80.50 D 232712 I See Footnote Class A Common Stock 2024-06-24 4 S false 190 80.98 D 232522 I See Footnote Class A Common Stock 1427197 D These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 21, 2023. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $78.88 to $79.87, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, Nuvalent, Inc. or any security holder of Nuvalent, Inc., upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (4) and (5) of this Form 4. These shares are held by Matthew D. Shair 2021 Irrevocable Family Trust. The reporting person has voting and dispositive power over the shares beneficially owned by Matthew D. Shair 2021 Irrevocable Family Trust. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $79.88 to $80.87, inclusive. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $80.89 to $81.15, inclusive. /s/ Nathan McConarty, attorney-in-fact 2024-06-26